Boehringer Ingelheim Venture Fund

CVCIngelheim am Rhein, Germanywww.boehringer-ingelheim-venture.com

Boehringer Ingelheim Venture Fund is dedicated to advancing scientific innovation in therapeutics.

What they invest in

Stages

Seed Series A Series B

Sectors

Biotech & Pharma HealthTech

Geographies

EUUSChina

The facts

Typical cheque: €1M – €30M
Headquarters: Ingelheim am Rhein, Germany
Founded: 2010

Portfolio

Agomab Therapeutics (NAS: AGMB)NBE TherapeuticsHookipa Pharma (OTCM: HOOK)RigontecAelin TherapeuticsEvlaBioCellaïonArrePathProTgen (Drug Discovery)Optina DiagnosticsImCheck TherapeuticsAnagenesis BiotechnologiesAsgard TherapeuticseTheRNADelonix BioworksTopas TherapeuticsAcousia TherapeuticsAbalos TherapeuticsEpsilogenRefoxy PharmaBrainomixWellth (Healthcare Technology Systems)DiogenXPulseSight Therapeutics

and 26 more

Does Boehringer Ingelheim Venture Fund fit your round?

Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.

Check your match

Are you Boehringer Ingelheim Venture Fund? Tell us what to correct and we will update it — or ask us to remove the entry.